AngioSafe, Inc.


AngioSafe is dedicated to solving complex interventional challenges in coronary and peripheral arterial diseases through a series of patented devices and a highly experienced team. Since 2014, the company has been advancing innovative solutions to enable and improve vascular interventions, with plans for commercial approvals and launches.

Industries

health-diagnostics
medical
medical-device

Nr. of Employees

small (1-50)

AngioSafe, Inc.

San Jose, California, United States, North America


Products

Patented catheter-based vascular device series

A series of patented catheter-based devices targeting coronary and peripheral arterial disease; devices are at various stages of preclinical and clinical development.


Services

Clinical development partnerships

Collaborative clinical programs with advanced centers and principal investigators to conduct clinical evaluation of interventional vascular devices.

Regulatory and clinical strategy advisory

Strategic advisory services for regulatory planning, nonclinical study design, and clinical strategy to support device development and submissions.

Expertise Areas

  • Interventional cardiology device development
  • Clinical trial management and investigator-led programs
  • Regulatory strategy and quality management for medical devices
  • Preclinical and nonclinical testing
  • Show More (3)

Key Technologies

  • Catheter-based endovascular device platforms
  • Endovascular device prototyping and design validation
  • Preclinical study methods for vascular devices
  • Clinical trial coordination for device evaluation
  • Show More (1)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.